Dongguk University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Seoul Korea, Republic of (1906)

Organization Overview

First Clinical Trial
2007
NCT01820728
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of anesthesiology, Dongguk University Il-san hospital | Department of Urology, Dongguk University Gyeongju Hospital | Dept. of anesthesiology and pain medicine, Dongguk University Ilsan Hospital | Donggguk University Ilsan Hospital | DongGuk universit hospital Gyeongju hospital | DongGuk University | Dongguk university Bundang Oriental Hospital | DongGuk University College of Medicine | Dongguk University College of Medicine and Ilsan Hospital | Dongguk University Gyeongju Hospital of Korea | Dongguk University Hospital | Dongguk University Ilsan Hospital, Korea | Dongguk University Ilsan Oriental Hospital | Dongguk University International Hospital | Dongguk University International Hospital, Siksa-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do, Korea | Dongguk University Medical Center | Eun Jung Kim | Namyi Gu

Active Ingredients

Drugs in Phase 4 Trials (16)

5,7-dihydroxy-3',4',6-trimethoxyflavone (1 trial)

adefovir dipivoxil (hepsera) (1 trial)

conjugated linoleic acid (1 trial)

daesiho-tang (1 trial)

danggui-sayuk-ga-osuyu-saenggang-tang (1 trial)

dexmedetomidine (precedex) (1 trial)

evogliptin (1 trial)

ilaprazole (noltec) (1 trial)

jowiseungcheung-tang (1 trial)

lamivudine (epivir) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

rebamipide (1 trial)

rowachol (1 trial)

sodium chloride (2 trials)

tenofovir (viread) (1 trial)

thioctic acid (1 trial)

Drugs in Phase 3 Trials (25)

agsct101 (1 trial)

amlodipine (norvasc) (3 trials)

asiasarum sieboldi f. maekawa (1 trial)

bosinji (1 trial)

carvedilol (coreg) (1 trial)

cellulose (1 trial)

cinnamomum cassia (1 trial)

ephedra (1 trial)

fimasartan (kanarb) (4 trials)

follitropin alfa (1 trial)

ginseol kg1 (1 trial)

glycyrrhiza (1 trial)

HCP1803 (2 trials)

hydrochlorothiazide (esidrix) (1 trial)

losartan (cozaar) (4 trials)

loxoprofen (1 trial)

moxifloxacin (avelox) (1 trial)

paeonia lactiflora (1 trial)

rhizoma pinelliae (1 trial)

rimabotulinumtoxinB (Myobloc) (1 trial)

schisandra chinensis (1 trial)

vitamin c (1 trial)

vitamin d3 (1 trial)

zabofloxacin (1 trial)

Zingiber officinale (1 trial)

Drugs in Phase 2 Trials (9)

caffeine (1 trial)

gv 1001 (1 trial)

hpp2005 (1 trial)

midazolam (versed) (1 trial)

propofol (diprivan) (1 trial)

remifentanil (ultiva) (1 trial)

rld2003 (1 trial)

rld2004 (1 trial)

rld2005 (1 trial)

Drugs in Phase 1 Trials (3)

clozapine (clozaril) (1 trial)

s. baicalensis (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Other Trials (9)

actinidia arguta (1 trial)

clarithromycin (biaxin) (1 trial)

colistin (1 trial)

desflurane (suprane) (1 trial)

ginseng (1 trial)

isoflurane (forane) (1 trial)

levofloxacin (levaquin) (1 trial)

sevoflurane (ultane) (1 trial)

vaccinium uliginosum extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anovulation (Phase 3)

Cancer Pain (Phase 2)

Communicable Diseases (Phase 4)

Cryopyrin-Associated Periodic Syndromes (Phase 4)

Diabetes Mellitus (Phase 1)

Diabetes Mellitus, Type 2 (Phase 4)

Diabetic Neuropathies (Phase 4)

Dry Eye Syndromes (Phase 3)

Essential Hypertension (Phase 3)

Fatigue (Phase 3)

Gastritis (Phase 4)

Helicobacter Infections (Phase 4)

Hepatitis (Phase 4)

Hepatitis A (Phase 4)

Hepatitis B (Phase 4)

Hepatitis B, Chronic (Phase 4)

Hepatitis, Chronic (Phase 4)

Hernia (Phase 3)

Hyperplasia (Phase 2)

Hypersensitivity (Phase 4)

Hypertension (Phase 3)

Infections (Phase 4)

Infertility (Phase 3)

Keratoconjunctivitis Sicca (Phase 3)

Lung Diseases (Phase 3)

Lung Diseases, Obstructive (Phase 3)

Metabolic Syndrome (Phase 4)

Muscle Spasticity (Phase 3)

Osteoporosis (Phase 4)

Postcholecystectomy Syndrome (Phase 4)

Prehypertension (Phase 3)

Premature Birth (Phase 2)

Prostatic Hyperplasia (Phase 2)

Pulmonary Disease, Chronic Obstructive (Phase 3)

Radiculopathy (Phase 3)

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Perennial (Phase 3)

Schizophrenia (Phase 1)

Syndrome (Phase 4)

Vitamin D Deficiency (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 38
  • # of Trial APIs: 62